| Andrew Harmon, MD | |
|
9100 W 74th St, Shawnee Mission, KS 66204-4004 | |
| (913) 676-2310 | |
| Not Available |
| Full Name | Andrew Harmon |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 25 Years |
| Location | 9100 W 74th St, Shawnee Mission, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396762746 | NPI | - | NPPES |
| 100428540B | Medicaid | KS | |
| 209263102 | Medicaid | MO | |
| 34095012 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 04-29724 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Liberty Hospital District | Liberty, MO | Hospital |
| Cameron Regional Medical Center | Cameron, MO | Hospital |
| Harrison County Community Hospital | Bethany, MO | Hospital |
| Mercy Hospital Joplin | Joplin, MO | Hospital |
| Bothwell Regional Health Center | Sedalia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alliance Radiology Pa | 8426961517 | 33 |
| Johnson County Imaging Center, Inc | 8628978053 | 28 |
| Alliance Radiology Pa | 8426961517 | 33 |
News Archive
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
The New York private equity firm that last week struck a deal to buy Caritas Christi Health Care could build the chain of six Catholic community hospitals into a competitive lower-cost provider of medical services in Massachusetts, touting it as a profitable national business model in the age of health care reform, analysts say.
A new NPR/Robert Wood Johnson Foundation/Harvard School of Public Health poll was released today on the views of Latinos in America about their health and health care, communities, financial situation, and discrimination in their lives. The poll found that Latinos see diabetes as the biggest health problem for their own families.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
› Verified 4 days ago
| Entity Name | Alliance Radiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467400663 PECOS PAC ID: 8426961517 Enrollment ID: O20050721001061 |
News Archive
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
The New York private equity firm that last week struck a deal to buy Caritas Christi Health Care could build the chain of six Catholic community hospitals into a competitive lower-cost provider of medical services in Massachusetts, touting it as a profitable national business model in the age of health care reform, analysts say.
A new NPR/Robert Wood Johnson Foundation/Harvard School of Public Health poll was released today on the views of Latinos in America about their health and health care, communities, financial situation, and discrimination in their lives. The poll found that Latinos see diabetes as the biggest health problem for their own families.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
› Verified 4 days ago
| Entity Name | Johnson County Imaging Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720135114 PECOS PAC ID: 8628978053 Enrollment ID: O20051027000420 |
News Archive
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
The New York private equity firm that last week struck a deal to buy Caritas Christi Health Care could build the chain of six Catholic community hospitals into a competitive lower-cost provider of medical services in Massachusetts, touting it as a profitable national business model in the age of health care reform, analysts say.
A new NPR/Robert Wood Johnson Foundation/Harvard School of Public Health poll was released today on the views of Latinos in America about their health and health care, communities, financial situation, and discrimination in their lives. The poll found that Latinos see diabetes as the biggest health problem for their own families.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
› Verified 4 days ago
| Entity Name | Regional Imaging, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992768683 PECOS PAC ID: 5991713885 Enrollment ID: O20140313000920 |
News Archive
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
The New York private equity firm that last week struck a deal to buy Caritas Christi Health Care could build the chain of six Catholic community hospitals into a competitive lower-cost provider of medical services in Massachusetts, touting it as a profitable national business model in the age of health care reform, analysts say.
A new NPR/Robert Wood Johnson Foundation/Harvard School of Public Health poll was released today on the views of Latinos in America about their health and health care, communities, financial situation, and discrimination in their lives. The poll found that Latinos see diabetes as the biggest health problem for their own families.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
› Verified 4 days ago
| Entity Name | Chippewa Valley Hospital & Oakview Care Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659471068 PECOS PAC ID: 6901700517 Enrollment ID: O20230724001038 |
News Archive
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
The New York private equity firm that last week struck a deal to buy Caritas Christi Health Care could build the chain of six Catholic community hospitals into a competitive lower-cost provider of medical services in Massachusetts, touting it as a profitable national business model in the age of health care reform, analysts say.
A new NPR/Robert Wood Johnson Foundation/Harvard School of Public Health poll was released today on the views of Latinos in America about their health and health care, communities, financial situation, and discrimination in their lives. The poll found that Latinos see diabetes as the biggest health problem for their own families.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Harmon, MD 8000 W 110th St, Ste 150, Overland Park, KS 66210-2338 Ph: (913) 599-6777 | Andrew Harmon, MD 9100 W 74th St, Shawnee Mission, KS 66204-4004 Ph: (913) 676-2310 |
News Archive
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.
The New York private equity firm that last week struck a deal to buy Caritas Christi Health Care could build the chain of six Catholic community hospitals into a competitive lower-cost provider of medical services in Massachusetts, touting it as a profitable national business model in the age of health care reform, analysts say.
A new NPR/Robert Wood Johnson Foundation/Harvard School of Public Health poll was released today on the views of Latinos in America about their health and health care, communities, financial situation, and discrimination in their lives. The poll found that Latinos see diabetes as the biggest health problem for their own families.
Epizyme today announced a worldwide strategic alliance with GlaxoSmithKline to discover, develop, and market novel small molecule therapeutics targeting histone methyltransferases, an important class of epigenetic enzymes, for the treatment of cancer and other diseases.
› Verified 4 days ago
Michael J Gaughan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
John Yungmeyer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Jeffrey A Hicklin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Richard D Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Miss Kavita Chowdary Gorantla, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Michael W Dennis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Mark S Reinsel, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-599-6777 |